Dr. Cornelia Weyand's research interests include autoimmunity, chronic inflammatory disease, and metabolic control of immune function.

Dr. Weyand is an elected member of the American Society for Clinical Investigation and the American Association of Physicians. She was named a Notable Woman in Science and Medicine by the Helmholtz Association. The National Institutes of Health have continuously supported her research program since 1993. She has presented forty-four named lectureships and given more than 400 presentations. Her research team has published more than 450 manuscripts. Her current H-index is 138, documenting her wide-reaching impact in the scientific community.

Dr. Weyand's contributions to science have followed the arc of how immune responses deviate from host protection to tissue damage. Her primary focus has been on autoimmune diseases; specifically, atherosclerotic disease and the vasculitides.